REGN Regeneron Pharmaceuticals, Inc. - Common Stock
$837,77
Prix · Aoû 21, 2026
Données fondamentales au Jul 30, 2026
Fourchette 52 semaines
$541–$845
98% of range
Note des analystes
BUY
37 analysts
Objectif de cours
$840
+0% upside
P/E (TTM)
20.2
ROE
14.7%
Marge nette
31.4%
À propos de Regeneron Pharmaceuticals, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
Regeneron Pharmaceuticals est une entreprise de biotechnologie américaine produisant notamment le Rilonacept. Elle est domiciliée à Tarrytown, dans l'État de New York.
Lire la suite
Regeneron Pharmaceuticals est une entreprise de biotechnologie américaine produisant notamment le Rilonacept. Elle est domiciliée à Tarrytown, dans l'État de New York.
Son directeur général et fondateur est Leonard Schleifer (en).
Histoire
En juillet 2015, Sanofi signe un partenariat sur le cancer avec Regeneron d'environ 2 milliards de dollars.
En mai 2020, Sanofi annonce la vente de sa participation de 20,6 % dans Regeneron pour près de 13 milliards de dollars.
En août 2020, Regeneron annonce son association avec le laboratoire suisse Roche en vue de « développer, fabriquer et distribuer REGN-COV2 ». Il s'agit d'une combinaison d'anticorps expérimentaux destinés à lutter contre l'épidémie de Covid-19. En octobre 2020, les médecins du président Donald Trump, contaminé par le Covid-19 et hospitalisé au centre militaire de Walter Reed, lui prescrivent le Regn-Cov2 associé avec l'antiviral Remdésivir et un corticoïde, le dexamethasone. Le docteur Leonard Schleifer « ne pouvait qu’accepter d’aider le président américain, qui est l’un de ses proches amis. Donald Trump et Leonard Schleifer jouent régulièrement au golf ensemble. C’est d’ailleurs certainement en tapant dans la balle, que Donald Trump a conclu que le gouvernement américain financerait à hauteur de 600 millions de dollars le développement du REGN-COV2 ». Le 8 octobre, de retour à la Maison-Blanche, le président affirme que l'autorité sanitaire, la Food and Drug Administration, allait autoriser sa mise sur le marché en urgence. La Food and Drug Administration autorise le traitement le 21 novembre 2020. Finalement Regeneron a reçu plus de 450 millions de dollars du gouvernement américain pour ses efforts de développement de médicaments contre la Covid-19. Fin février 2021, l'Agence européenne des médicaments (EMA) délivre un avis favorable à la prescription et à la commercialisation de ce traitement.
En mai 2025, Regeneron acquiert 23andMe, en faillite, pour 256 millions de dollars.
Références
Portail des entreprises Portail de New York
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
REGN Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$837.77
Capitalisation Boursière
$115.53B
P/E (TTM)
20.2
BPA (TTM)
$41.48
Revenus (TTM)
$14.34B
Rendement div.
0.32%
ROE
14.7%
Dette/Capitaux propres
0.1
Fourchette 52 semaines
$541 – $845
REGN Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$14.34B
2016-12-31
→
2025-12-31
BPA
$41.48
2016-12-31
→
2025-12-31
Flux de trésorerie libre
$4.08B
2016-12-31
→
2025-12-31
Marges
31.4%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
REGN
Médiane des pairs
P/E (TTM)
20.2
17.7
P/S (TTM)
8.1
6.8
P/B
3.7
6.4
EV / EBITDA
26.4
—
Price / FCF (Cours / FCF)
28.3
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
REGN
Médiane des pairs
Operating Margin (Marge d'exploitation)
24.9%
—
Net Profit Margin (Marge nette)
31.4%
20.3%
ROA
11.5%
11.4%
ROE
14.7%
16.8%
ROIC
9.3%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
REGN
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.1
—
Current Ratio (Ratio de liquidité)
4.1
3.4
Quick Ratio (Ratio de liquidité réduite)
3.3
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
REGN
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
0.99%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
5.6%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
11.0%
—
EPS YoY (BPA Année/Année)
8.2%
—
Net Income YoY (Bénéfice net YoY)
2.1%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
REGN
Médiane des pairs
Payout Ratio (Ratio de distribution)
8.2%
—
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
0.32%
Ratio de distribution
8.2%
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 18 août 2026 | $0,9400 |
| 20 mai 2026 | $0,9400 |
| 20 février 2026 | $0,9400 |
| 20 novembre 2025 | $0,8800 |
| 18 août 2025 | $0,8800 |
| 20 mai 2025 | $0,8800 |
| 20 février 2025 | $0,8800 |
REGN Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
37 analystes
- Achat fort 8 21,6%
- Achat 18 48,6%
- Conserver 11 29,7%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
27 analystes · 2026-08-19
Médiane
$824.00
Maintenant
$837.77
Bas
$730.00
Haut
$1030.00
Objectif médian
$824.00
-1,6%
Objectif moyen
$840.43
+0,3%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
1.7%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $14.29 | $10.47 | 3.8% |
| 31 mars 2026 | $9.47 | $9.12 | 0.35% |
| 31 décembre 2025 | $11.44 | $10.83 | 0.61% |
| 30 septembre 2025 | $11.83 | $9.78 | 2.0% |
| 30 juin 2025 | $12.89 | $8.61 | 4.3% |
| 31 mars 2025 | $8.22 | $9.00 | -0.78% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| ABBV | — | 96.8 | 8.6% | 6.9% | 15367.3% | — |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Cost of Revenue | · | · | · | · | · | · | $403M | $238M | $203M | $195M | $242M | $129M | |
| R&D Expense | $5.85B | $5.13B | $4.44B | $3.59B | $2.86B | $2.65B | $2.45B | $1.47B | $2.08B | $2.05B | $1.62B | $1.27B | |
| SG&A Expense | $2.70B | $2.95B | $2.63B | $2.12B | $1.82B | $1.35B | $1.34B | $1.13B | $1.32B | $1.18B | $839M | $519M | |
| Operating Expenses | $10.77B | $10.21B | $9.07B | $7.43B | $7.12B | $4.92B | $4.35B | $2.61B | $3.79B | $3.53B | $2.85B | $2.00B | |
| Operating Income | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B | $3.58B | $2.21B | $2.53B | $2.08B | $1.33B | $1.25B | $824M | |
| Interest Expense | · | · | $73M | $59M | $57M | $57M | $30M | $28M | $25M | $7M | $14M | $37M | |
| Other Non-op | $1.70B | $844M | $225M | $179M | $436M | $291M | $250M | $47M | $24M | $6M | $-13M | $-25M | |
| Pretax Income | $5.23B | $4.78B | $4.20B | $4.86B | $9.33B | $3.81B | $2.43B | $2.55B | $2.08B | $1.33B | $1.23B | $761M | |
| Income Tax | $726M | $367M | $246M | $520M | $1.25B | $297M | $313M | $109M | $880M | $434M | $589M | $423M | |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| EPS (Basic) | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 | $32.65 | $19.38 | $22.65 | $11.27 | $8.55 | $6.17 | $3.36 | |
| EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $30.52 | $18.46 | $21.29 | $10.34 | $7.70 | $5.52 | $2.98 | |
| Shares (Basic) | 104,600,000 | 107,900,000 | 106,700,000 | 107,100,000 | 105,700,000 | 107,600,000 | 109,200,000 | 107,900,000 | 106,300,000 | 104,700,000 | 103,061,000 | 100,612,000 | |
| Shares (Diluted) | 108,600,000 | 115,100,000 | 113,700,000 | 113,500,000 | 112,200,000 | 115,100,000 | 114,600,000 | 114,800,000 | 115,900,000 | 116,300,000 | 115,230,000 | 113,413,000 | |
| EBITDA | $4.12B | $4.47B | $4.47B | $5.08B | $9.23B | $3.81B | $2.42B | $2.68B | $2.23B | $1.44B | $1.33B | $891M |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.12B | $2.49B | $2.73B | $3.11B | $2.89B | $2.19B | $1.62B | $1.47B | $813M | $535M | $809M | $649M | |
| Short-term Investments | $5.49B | $6.52B | $8.11B | $4.64B | $2.81B | $1.39B | $1.60B | $1.34B | $597M | $503M | $236M | $252M | |
| Receivables | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B | $4.11B | $2.10B | $1.72B | $1.54B | $1.34B | $1.15B | $739M | |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B | $1.92B | $1.42B | $1.15B | $726M | $399M | $239M | $129M | |
| Prepaid Expense | $475M | $349M | $387M | $411M | $332M | $161M | $274M | $243M | $225M | $131M | $164M | $79M | |
| Current Assets | $18.02B | $18.66B | $19.48B | $15.88B | $14.01B | $9.78B | $7.69B | $6.45B | $4.33B | $3.18B | $2.92B | $2.08B | |
| PP&E (Net) | · | · | · | · | $3.48B | $3.22B | $2.89B | $2.58B | $2.36B | $2.08B | $1.59B | $974M | |
| PP&E (Gross) | · | · | · | · | · | · | $3.81B | $3.30B | $2.92B | $2.51B | $1.93B | $1.23B | |
| Accum. Depreciation | · | · | · | · | · | · | $922M | $729M | $566M | $426M | $331M | $254M | |
| Intangibles | $1.26B | $1.15B | $1.04B | $916M | $7M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.82B | $1.14B | $444M | $336M | $216M | $168M | $145M | $127M | $78M | $20M | $6M | $3M | |
| Total Assets | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Accounts Payable | $939M | $790M | $607M | $589M | $564M | $476M | $418M | $218M | $178M | $879M | $644M | $483M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $4.37B | $3.94B | $3.42B | $3.14B | $3.93B | $2.70B | $2.10B | $1.44B | $1.14B | $1.24B | $811M | $655M | |
| Capital Leases | $229M | $204M | $69M | $56M | · | · | · | $708M | · | · | · | · | |
| Other Non-current Liabilities | $2.02B | $1.57B | $854M | $638M | $680M | $687M | $318M | $362M | $152M | $100M | $116M | $40M | |
| Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B | $6.14B | $3.72B | $2.98B | $2.62B | $2.52B | $1.95B | $1.29B | |
| Total Debt | $1.99B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | · | · | · | · | · | · | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $108.0K | $106.0K | $102.0K | |
| Paid-in Capital | $13.99B | $12.86B | $11.35B | $9.95B | $8.09B | $6.72B | $4.43B | $3.91B | $3.51B | $3.03B | $3.10B | $2.45B | |
| Retained Earnings | $35.80B | $31.67B | $27.26B | $23.31B | $18.97B | $10.89B | $7.38B | $5.25B | $2.95B | $1.75B | $853M | $217M | |
| Treasury Stock | $18.61B | $15.17B | $12.56B | $10.35B | $8.26B | $6.61B | $740M | $396M | $316M | $316M | $306M | $170M | |
| AOCI | $78M | $-8M | $-81M | $-239M | $-26M | $29M | $21M | $-12M | $600.0K | $-13M | $9M | $52M | |
| Stockholders' Equity | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B | $11.03B | $11.09B | $8.76B | $6.14B | $4.45B | $3.65B | $2.55B | |
| Liabilities + Equity | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Shares Outstanding | 137,600,000 | 136,000,000 | 133,100,000 | 130,400,000 | 126,200,000 | 121,500,000 | 113,300,000 | · | · | · | · | · |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $544M | $483M | $421M | $341M | $286M | $236M | $210M | $148M | $146M | $105M | $75M | $53M | |
| Stock-based Comp | $994M | $983M | $885M | $725M | $602M | $432M | $464M | $427M | $507M | $560M | $459M | $322M | |
| Deferred Tax | $-785M | $-757M | $-838M | $-746M | $-147M | $76M | $-131M | $-140M | $319M | $-360M | $-130M | $-46M | |
| Amort. of Intangibles | $179M | $129M | $92M | $38M | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $-278M | $-700M | $172M | $356M | $-1.73B | $-1.64B | $-230M | $-685M | $-863M | $273M | $291M | $86M | |
| Operating Cash Flow | $4.98B | $4.42B | $4.59B | $5.01B | $7.08B | $2.62B | $2.43B | $2.20B | $1.31B | $1.49B | $1.33B | $752M | |
| CapEx | $898M | $756M | $719M | $590M | $552M | $615M | $430M | $383M | $273M | $512M | $678M | $333M | |
| Investing Cash Flow | $-629M | $-2.47B | $-3.19B | $-3.78B | $-5.38B | $-71M | $-2.03B | $-1.46B | $-1.01B | $-1.05B | $-908M | $-421M | |
| Debt Issued | · | · | · | $0 | $0 | $1.98B | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $1.98B | · | · | · | · | · | · | |
| Stock Issued | $636M | $1.47B | $1.15B | $1.52B | $1.67B | $2.58B | $212M | $114M | $240M | $127M | $206M | $126M | |
| Stock Repurchased | $3.44B | $2.60B | $2.23B | $2.08B | $1.65B | $5.85B | $276M | $4M | $0 | $0 | · | · | |
| Net Stock Activity | $-2.80B | $-1.14B | $-1.09B | $-563M | $27M | $-3.27B | $-64M | $110M | $240M | $127M | $206M | $126M | |
| Dividends Paid | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-3.72B | $-2.20B | $-1.79B | $-1.01B | $-1.01B | $-1.97B | $-252M | $-77M | $-24M | $-700M | $-263M | $-219M | |
| Net Change in Cash | $635M | $-249M | $-382M | $221M | $691M | $577M | $150M | $655M | $278M | $-261M | $160M | $113M | |
| Taxes Paid | $1.25B | $743M | $870M | $1.50B | $1.22B | $188M | $342M | $206M | $755M | $481M | $276M | $60M | |
| Free Cash Flow | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B | $2.00B | $2.00B | $1.81B | $1.03B | $961M | $653M | $410M | |
| Levered FCF | · | · | $3.81B | $4.37B | $6.48B | $1.95B | $1.97B | $1.79B | · | · | $645M | $393M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% | 42.1% | 28.1% | 37.8% | 35.4% | 27.4% | 30.5% | 29.7% | |
| Net Margin | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% | 41.3% | 26.9% | 36.4% | 20.4% | 18.4% | 15.5% | 12.3% | |
| Pretax Margin | 36.5% | 33.7% | 32.0% | 39.9% | 58.0% | 44.8% | 30.9% | 38.0% | 35.4% | 27.4% | 29.8% | 27.5% | |
| EBITDA Margin | 28.7% | 31.5% | 34.1% | 41.7% | 57.5% | 44.9% | 30.8% | 40.0% | 37.9% | 29.5% | 32.3% | 31.6% | |
| ROA | 11.5% | 12.5% | 12.7% | 15.9% | 37.9% | 22.0% | 15.9% | 23.8% | 15.2% | 14.2% | 13.5% | 10.2% | |
| ROE | 14.7% | 15.0% | 15.5% | 19.7% | 44.8% | 33.2% | 19.6% | 29.4% | 22.6% | 22.1% | 20.5% | 15.4% | |
| ROIC | 9.3% | 11.8% | 13.6% | 17.2% | 37.3% | 25.4% | 17.4% | 27.7% | 19.5% | 20.1% | 17.8% | 14.8% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 | 3.6 | 3.7 | 4.5 | 3.8 | 2.6 | 3.6 | 3.3 | |
| Quick Ratio | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 | 2.5 | 2.5 | 3.1 | 2.6 | 1.9 | 2.7 | 2.5 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| Interest Coverage | · | · | 55.4 | 79.8 | 156.1 | 62.9 | 73.2 | 89.9 | · | · | 87.9 | 22.4 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.8 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 0.4 | 0.6 | 1.3 | 1.3 | |
| Receivables Turnover | 2.4 | 2.4 | 2.4 | 2.1 | 3.2 | 3.3 | 4.1 | 4.1 | 4.1 | 3.9 | 4.3 | 3.7 |
Taux de croissance 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.99% | 8.3% | 7.8% | -24.3% | 89.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.6% | -4.0% | 15.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 8.2% | 10.3% | -9.0% | -46.9% | 135.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 2.8% | -18.9% | 4.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 6.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | 11.6% | -8.9% | -46.3% | 129.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | -18.2% | 4.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Net Income TTM | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| Market Cap | $106.21B | $96.88B | $116.90B | $94.08B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $99.59B | $89.85B | $108.04B | $88.32B | · | · | · | · | · | · | · | · | |
| P/E | 18.6 | 18.6 | 25.3 | 18.9 | 8.8 | 15.8 | 20.3 | 17.5 | 36.4 | 47.7 | 98.3 | 137.7 | |
| P/S | 7.4 | 6.8 | 8.9 | 7.7 | · | · | · | · | · | · | · | · | |
| P/B | 3.4 | 3.3 | 4.5 | 4.2 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 3.5 | 3.4 | 4.7 | 4.3 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 21.3 | 21.9 | 25.4 | 18.8 | · | · | · | · | · | · | · | · | |
| P / FCF | 26.0 | 26.4 | 30.2 | 21.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 24.2 | 20.1 | 24.2 | 17.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | 24.4 | 24.5 | 27.9 | 20.0 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.9 | 6.3 | 8.2 | 7.3 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.35% | 0.00% | 0.00% | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.4% | 5.4% | 4.0% | 5.3% | 11.4% | 6.3% | 4.9% | 5.7% | 2.8% | 2.1% | 1.0% | 0.73% | |
| Payout Ratio | 8.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B | $3.03B | $3.79B | $3.72B | $3.55B | $3.15B | $3.43B | $3.36B | $3.16B | $3.16B | $3.41B | $2.94B | |
| R&D Expense | $1.63B | $1.54B | $1.63B | $1.48B | $1.42B | $1.33B | $1.41B | $1.27B | $1.20B | $1.25B | $1.18B | $1.08B | $1.09B | $1.10B | $1.04B | $911M | |
| SG&A Expense | $662M | $648M | $775M | $658M | $634M | $633M | $792M | $714M | $759M | $689M | $738M | $640M | $652M | $601M | $660M | $529M | |
| Operating Expenses | $3.00B | $2.96B | $3.00B | $2.73B | $2.60B | $2.44B | $2.80B | $2.54B | $2.48B | $2.39B | $2.46B | $2.25B | $2.14B | $2.22B | $2.27B | $1.71B | |
| Operating Income | $1.29B | $643M | $880M | $1.03B | $1.08B | $592M | $990M | $1.18B | $1.07B | $751M | $973M | $1.11B | $1.02B | $947M | $1.15B | $1.22B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $18M | $19M | $18M | · | $15M | |
| Other Non-op | $245M | $201M | $176M | $756M | $443M | $322M | $-22M | $327M | $573M | $-35M | $193M | $18M | $85M | $-71M | $195M | $301M | |
| Pretax Income | $1.53B | $831M | $1.04B | $1.76B | $1.52B | $905M | $958M | $1.49B | $1.63B | $701M | $1.15B | $1.11B | $1.08B | $858M | $1.32B | $1.51B | |
| Income Tax | $231M | $104M | $199M | $303M | $127M | $96M | $40M | $152M | $196M | $-21M | $-12M | $103M | $114M | $40M | $128M | $194M | |
| Net Income | $1.30B | $727M | $845M | $1.46B | $1.39B | $809M | $918M | $1.34B | $1.43B | $722M | $1.16B | $1.01B | $968M | $818M | $1.20B | $1.32B | |
| EPS (Basic) | $12.62 | $6.99 | $8.16 | $14.09 | $13.24 | $7.58 | $8.55 | $12.40 | $13.25 | $6.70 | $10.88 | $9.48 | $9.05 | $7.64 | $11.18 | $12.31 | |
| EPS (Diluted) | $12.23 | $6.75 | $7.78 | $13.62 | $12.81 | $7.27 | $8.12 | $11.54 | $12.41 | $6.27 | $10.21 | $8.89 | $8.50 | $7.17 | $10.48 | $11.66 | |
| Shares (Basic) | 102,800,000 | 104,000,000 | -210,800,000 | 103,600,000 | 105,100,000 | 106,700,000 | -216,100,000 | 108,100,000 | 108,100,000 | 107,800,000 | -213,700,000 | 106,300,000 | 107,000,000 | 107,100,000 | -214,500,000 | 106,900,000 | |
| Shares (Diluted) | 106,000,000 | 107,700,000 | -218,400,000 | 107,200,000 | 108,600,000 | 111,200,000 | -231,600,000 | 116,200,000 | 115,400,000 | 115,100,000 | -227,600,000 | 113,400,000 | 113,900,000 | 114,000,000 | -226,400,000 | 112,800,000 | |
| EBITDA | $1.29B | $766M | · | $1.03B | $1.08B | $719M | · | $1.18B | $1.07B | $866M | · | $1.11B | $1.02B | $1.05B | · | $1.22B |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.46B | $2.96B | $3.12B | $2.51B | $2.00B | $3.09B | $2.49B | $2.01B | $1.92B | $2.60B | $2.73B | $2.15B | $1.94B | $3.92B | $3.11B | $3.49B | |
| Short-term Investments | $5.54B | $5.79B | $5.49B | $5.94B | $5.47B | $5.26B | $6.52B | $7.78B | $7.89B | $7.92B | · | $7.76B | $6.99B | $5.04B | · | $3.53B | |
| Receivables | $6.57B | $5.73B | $5.74B | $5.69B | $5.61B | $5.56B | $6.21B | $6.11B | $5.72B | $5.22B | · | $5.58B | $5.12B | $5.12B | · | $5.55B | |
| Inventory | $3.08B | $3.10B | $3.20B | $3.25B | $3.21B | $3.19B | $3.09B | $3.02B | $2.87B | $2.71B | · | $2.56B | $2.51B | $2.42B | · | $2.41B | |
| Prepaid Expense | $802M | $621M | $475M | $596M | $574M | $469M | $349M | $412M | $682M | $415M | · | $575M | $366M | $406M | · | $446M | |
| Current Assets | $18.45B | $18.21B | $18.02B | $17.98B | $16.86B | $17.57B | $18.66B | $19.33B | $19.08B | $18.87B | · | $18.63B | $16.92B | $16.91B | · | $15.43B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.70B | |
| Intangibles | $1.31B | $1.29B | $1.26B | $1.38B | $1.35B | $1.17B | $1.15B | $1.12B | $1.10B | $1.06B | · | $1.02B | $953M | $929M | · | $804M | |
| Other Non-current Assets | $2.31B | $2.13B | $1.82B | $1.67B | $1.54B | $1.39B | $1.14B | $1.04B | $994M | $470M | · | $410M | $393M | $350M | · | $320M | |
| Total Assets | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Accounts Payable | $1.16B | $1.03B | $939M | $904M | $724M | $706M | $790M | $497M | $562M | $671M | · | $537M | $547M | $600M | · | · | |
| Current Liabilities | $5.53B | $5.11B | $4.37B | $4.43B | $3.67B | $3.57B | $3.94B | $3.66B | $3.51B | $3.58B | · | $3.60B | $3.10B | $3.10B | · | $2.88B | |
| Capital Leases | · | · | $229M | · | · | · | $204M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.28B | $2.13B | $2.02B | $1.86B | $1.70B | $1.67B | $1.57B | $1.54B | $1.46B | $908M | · | $832M | $717M | $677M | · | $599M | |
| Total Liabilities | $10.02B | $9.45B | $9.30B | $9.21B | $8.28B | $8.16B | $8.41B | $8.12B | $7.88B | $7.38B | · | $7.26B | $6.64B | $6.56B | · | $6.24B | |
| Total Debt | $1.99B | $1.99B | · | $1.99B | $1.99B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $14.70B | $14.40B | $13.99B | $13.79B | $13.49B | $13.19B | $12.86B | $12.70B | $12.32B | $11.94B | · | $11.25B | $10.89B | $10.60B | · | $9.52B | |
| Retained Earnings | $37.62B | $36.42B | $35.80B | $35.05B | $33.68B | $32.38B | $31.67B | $30.76B | $29.41B | $27.98B | · | $26.10B | $25.09B | $24.12B | · | $22.11B | |
| Treasury Stock | $20.57B | $19.41B | $18.61B | $17.94B | $17.28B | $16.22B | $15.17B | $14.19B | $13.46B | $12.86B | · | $12.27B | $11.77B | $11.05B | · | $9.91B | |
| AOCI | $-36M | $12M | $78M | $69M | $52M | $29M | $-8M | $60M | $-70M | $-77M | · | $-177M | $-198M | $-182M | · | $-275M | |
| Stockholders' Equity | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | $29.39B | $29.35B | $29.33B | $28.21B | $26.99B | $25.97B | $24.90B | $24.02B | $23.50B | $22.66B | $21.44B | |
| Liabilities + Equity | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Shares Outstanding | 138,000,000 | 137,900,000 | 137,600,000 | 136,200,000 | 136,200,000 | 136,100,000 | 136,000,000 | 135,300,000 | 134,800,000 | 134,200,000 | 133,100,000 | 132,100,000 | 131,600,000 | 131,400,000 | 130,400,000 | 129,000,000 |
Flux de trésorerie 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $145M | $137M | $135M | $127M | $126M | $122M | $121M | $114M | $113M | $105M | $103M | $100M | $100M | $93M | |
| Stock-based Comp | $243M | $257M | $249M | $237M | $252M | $256M | $304M | $225M | $223M | $230M | $240M | $204M | $202M | $239M | $232M | $166M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | $16M | |
| Other Non-cash | · | $-29M | · | · | · | $-146M | · | · | · | $446M | · | · | · | $212M | · | · | |
| Operating Cash Flow | $813M | $1.08B | $1.17B | $1.62B | $1.14B | $1.05B | $1.26B | $1.29B | $354M | $1.51B | $1.09B | $1.11B | $1.02B | $1.37B | $1.72B | $629M | |
| CapEx | $240M | $231M | $249M | $201M | $219M | $229M | $200M | $242M | $180M | $134M | $251M | $176M | $113M | $178M | $152M | $142M | |
| Investing Cash Flow | $-93M | $-429M | $220M | $-403M | $-1.09B | $648M | $351M | $-574M | $-557M | $-1.69B | $-66M | $-496M | $-2.39B | $-236M | $-1.86B | $192M | |
| Stock Issued | $49M | $163M | $504M | $40M | $32M | $61M | $91M | $255M | $438M | $682M | $301M | $269M | $91M | $485M | $373M | $318M | |
| Stock Repurchased | $1.17B | $794M | $672M | $664M | $1.06B | $1.04B | $973M | $735M | $604M | $291M | $289M | $546M | $689M | $711M | $431M | $935M | |
| Net Stock Activity | · | $-631M | · | · | · | $-981M | · | · | · | $391M | · | · | · | $-226M | · | · | |
| Dividends Paid | $97M | $98M | $93M | $91M | $93M | $94M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.22B | $-802M | $-780M | $-718M | $-1.13B | $-1.09B | $-1.14B | $-634M | $-478M | $47M | $-446M | $-407M | $-614M | $-322M | $-248M | $-725M | |
| Net Change in Cash | $-505M | $-153M | $611M | $498M | $-1.08B | $604M | $477M | $84M | $-682M | $-128M | $578M | $210M | $-1.98B | $809M | $-385M | $96M | |
| Free Cash Flow | · | $848M | · | · | · | $816M | · | · | · | $1.38B | · | · | · | $1.19B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.36B | · | · | · | $1.17B | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.1% | 17.8% | · | 27.4% | 29.4% | 19.5% | · | 31.7% | 30.1% | 23.9% | · | 33.0% | 32.2% | 29.9% | · | 41.7% | |
| Net Margin | 30.2% | 20.2% | · | 38.9% | 37.9% | 26.7% | · | 36.0% | 40.4% | 23.0% | · | 30.0% | 30.7% | 25.9% | · | 44.8% | |
| Pretax Margin | 35.6% | 23.1% | · | 47.0% | 41.3% | 29.9% | · | 40.1% | 45.9% | 22.3% | · | 33.0% | 34.3% | 27.1% | · | 51.4% | |
| EBITDA Margin | 30.1% | 21.2% | · | 27.4% | 29.4% | 23.7% | · | 31.7% | 30.1% | 27.5% | · | 33.0% | 32.2% | 33.1% | · | 41.7% | |
| ROA | 3.2% | 1.8% | · | 3.8% | 3.8% | 2.2% | · | 3.9% | 4.3% | 2.2% | · | 3.4% | 3.4% | 2.9% | · | 5.1% | |
| ROE | 4.2% | 2.4% | · | 4.8% | 4.8% | 2.9% | · | 4.9% | 5.5% | 2.9% | · | 4.3% | 4.3% | 3.8% | · | 6.8% | |
| ROIC | 3.3% | 1.7% | · | 2.6% | 3.1% | 1.7% | · | 3.4% | 3.1% | 2.7% | · | 3.8% | 3.5% | 3.5% | · | 4.5% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.6 | · | 4.1 | 4.6 | 4.9 | · | 5.3 | 5.4 | 5.3 | · | 5.2 | 5.5 | 5.5 | · | 5.4 | |
| Quick Ratio | 2.6 | 2.8 | · | 3.2 | 3.6 | 3.9 | · | 4.3 | 4.4 | 4.4 | · | 4.3 | 4.5 | 4.5 | · | 4.4 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 46.7 | · | 62.4 | 53.8 | 52.6 | · | 80.0 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 |
Valorisation (TTM) 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.33B | $14.06B | · | $14.18B | $13.97B | $13.44B | · | $13.78B | $13.21B | $12.83B | · | $12.62B | $12.11B | $11.92B | · | $12.21B | |
| Net Income TTM | $4.88B | $4.39B | · | $5.00B | $4.97B | $4.30B | · | $4.50B | $4.13B | $3.52B | · | $4.11B | $3.95B | $3.96B | · | $4.77B | |
| Market Cap | $86.05B | $106.55B | · | $76.58B | $71.50B | $86.32B | · | $142.23B | $141.68B | $129.17B | · | $108.71B | $94.56B | $107.97B | · | $88.86B | |
| Enterprise Value | $80.04B | $99.78B | · | $70.12B | $66.02B | $79.95B | · | $134.42B | $133.85B | $120.63B | · | $100.78B | $87.61B | $100.99B | · | $83.82B | |
| P/E | 13.7 | 19.1 | · | 12.4 | 11.9 | 16.9 | · | 26.9 | 29.1 | 31.2 | · | 22.7 | 20.6 | 23.5 | · | 16.4 | |
| P/S | 5.6 | 7.6 | · | 5.4 | 5.1 | 6.4 | · | 10.3 | 10.7 | 10.1 | · | 8.6 | 7.8 | 9.1 | · | 7.3 | |
| P/B | 2.7 | 3.4 | · | 2.5 | 2.4 | 2.9 | · | 4.9 | 5.0 | 4.8 | · | 4.4 | 3.9 | 4.6 | · | 4.1 | |
| P / Tangible Book | 2.8 | 3.5 | · | 2.6 | 2.5 | 3.1 | · | 5.0 | 5.2 | 5.0 | · | 4.6 | 4.1 | 4.8 | · | 4.3 | |
| P / Cash Flow | · | 98.8 | · | · | · | 82.6 | · | · | · | 85.4 | · | · | · | 78.9 | · | · | |
| P / FCF | · | 125.6 | · | · | · | 105.8 | · | · | · | 93.7 | · | · | · | 90.8 | · | · | |
| EV / EBITDA | 61.9 | 130.2 | · | 68.3 | 61.2 | 111.3 | · | 114.0 | 125.1 | 139.4 | · | 90.7 | 86.2 | 96.5 | · | 68.5 | |
| EV / FCF | · | 117.6 | · | · | · | 98.0 | · | · | · | 87.5 | · | · | · | 84.9 | · | · | |
| EV / Revenue | 5.2 | 7.1 | · | 4.9 | 4.7 | 5.9 | · | 9.8 | 10.1 | 9.4 | · | 8.0 | 7.2 | 8.5 | · | 6.9 | |
| Earnings Yield | 7.3% | 5.2% | · | 8.1% | 8.4% | 5.9% | · | 3.7% | 3.4% | 3.2% | · | 4.4% | 4.8% | 4.2% | · | 6.1% | |
| Payout Ratio | · | 13.5% | · | · | · | 11.6% | · | · | · | · | · | · | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| Marge d'exploitation % | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% |
| Résultat net | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B |
| BPA dilué | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Ratio de liquidité | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 |
| Ratio de liquidité réduite | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Le potentiel de gain de 20 % des avoirs de FDG
- L'ETF iShares MSCI USA Min Vol Factor connaît une forte sortie
- Regeneron Pharmaceuticals (REGN) annonce une collaboration avec Telix Pharmaceuticals Limited
- Aperçu des résultats : Que faut-il attendre du rapport de Regeneron Pharmaceuticals
- Regeneron Pharma s'associe à Telix Pharma pour développer conjointement des thérapies radiopharmaceutiques
- Jim Cramer sur Regeneron (REGN) : 'Je pense que l'action est en train de s'envoler ici'
- Telix et Regeneron s'associent pour faire progresser les thérapies radiopharmaceutiques de nouvelle génération
- Formycon sécurise le calendrier de lancement européen pour FYB203 après le règlement Regeneron, Bayer
- Regeneron Pharmaceuticals, Inc. (REGN) est-elle une bonne action à acheter ?
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 481 déclarants · $34.8B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 116 (-46 vs T. préc.) | 163 (+66 vs T. préc.) | 487 (-65 vs T. préc.) | 534 (+50 vs T. préc.) | -156K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4 133 919 926 | 6 629 759 | 11,89% | Actions |
| Dodge & Cox | $3 037 348 765 | 4 871 137 | 8,73% | Actions |
| STATE STREET CORP | $3 014 621 356 | 4 834 688 | 8,67% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 979 934 668 | 3 175 313 | 5,69% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 427 303 015 | 2 297 074 | 4,10% | Actions |
| LOOMIS SAYLES & CO L P | $1 014 501 372 | 1 627 003 | 2,92% | Actions |
| PeakShares LLC | $975 217 000 | 1 564 | 2,80% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $763 126 911 | 1 223 862 | 2,19% | Actions |
| NORGES BANK | $731 292 700 | 1 172 808 | 2,10% | Actions |
| Capital World Investors | $508 138 359 | 814 925 | 1,46% | Actions |
| TWO SIGMA ADVISERS, LP | $466 626 290 | 604 540 | 1,34% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $432 674 406 | 693 900 | 1,24% | Option de vente |
| TWO SIGMA INVESTMENTS, LP | $409 119 559 | 656 124 | 1,18% | Actions |
| GOLDMAN SACHS GROUP INC | $392 576 914 | 629 594 | 1,13% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $351 496 357 | 563 711 | 1,01% | Actions |
| FIRST TRUST ADVISORS LP | $341 158 711 | 547 132 | 0,98% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $299 532 285 | 480 373 | 0,86% | Actions |
| Robeco Institutional Asset Management B.V. | $287 203 770 | 460 602 | 0,83% | Actions |
| NEUBERGER BERMAN GROUP LLC | $259 935 179 | 416 870 | 0,75% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $249 320 598 | 399 847 | 0,72% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245 478 345 | 393 685 | 0,71% | Actions |
| National Pension Service | $236 829 845 | 379 815 | 0,68% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $236 259 306 | 378 900 | 0,68% | Option d'achat |
| ALLIANCEBERNSTEIN L.P. | $225 872 032 | 292 338 | 0,65% | Actions |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $220 714 454 | 353 970 | 0,63% | Actions |
| BlackRock, Inc. | $207 677 479 | 333 062 | 0,60% | Actions |
| JANE STREET GROUP, LLC | $198 659 844 | 318 600 | 0,57% | Option d'achat |
| Swiss National Bank | $182 709 691 | 293 020 | 0,53% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $175 962 364 | 282 199 | 0,51% | Actions |
| BANK OF AMERICA CORP /DE/ | $171 791 505 | 275 510 | 0,49% | Actions |
| CITADEL ADVISORS LLC | $169 166 402 | 271 300 | 0,49% | Option d'achat |
| FIL Ltd | $165 543 635 | 265 490 | 0,48% | Actions |
| CITADEL ADVISORS LLC | $164 988 684 | 264 600 | 0,47% | Option de vente |
| FMR LLC | $162 474 852 | 260 568 | 0,47% | Actions |
| TD Asset Management Inc | $161 694 522 | 259 317 | 0,46% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $160 530 373 | 257 450 | 0,46% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $159 939 881 | 256 503 | 0,46% | Actions |
| Nuveen, LLC | $158 965 911 | 254 941 | 0,46% | Actions |
| Caisse de depot et placement du Quebec | $156 264 112 | 250 608 | 0,45% | Actions |
| Assenagon Asset Management S.A. | $152 721 782 | 244 927 | 0,44% | Actions |
| Vanguard Global Advisers, LLC | $141 371 483 | 226 724 | 0,41% | Actions |
| California Public Employees Retirement System | $139 840 692 | 224 269 | 0,40% | Actions |
| Qube Research & Technologies Ltd | $138 180 829 | 221 607 | 0,40% | Actions |
| Legal & General Group Plc | $134 385 341 | 215 520 | 0,39% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $130 887 905 | 209 911 | 0,38% | Actions |
| Squarepoint Ops LLC | $123 814 467 | 198 567 | 0,36% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $123 317 506 | 197 770 | 0,35% | Actions |
| Candriam S.C.A. | $121 893 176 | 195 674 | 0,35% | Actions |
| MCDONALD CAPITAL INVESTORS INC/CA | $120 366 915 | 193 038 | 0,35% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $119 141 861 | 154 201 | 0,34% | Actions |
| Swedbank AB | $118 377 821 | 189 848 | 0,34% | Actions |
| Carmignac Gestion | $113 826 706 | 182 507 | 0,33% | Actions |
| BANK OF NOVA SCOTIA | $113 300 959 | 181 706 | 0,33% | Actions |
| JANE STREET GROUP, LLC | $112 548 970 | 180 500 | 0,32% | Option de vente |
| BARCLAYS PLC | $111 306 254 | 178 507 | 0,32% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $109 300 950 | 175 291 | 0,31% | Actions |
| GOLDMAN SACHS GROUP INC | $106 687 694 | 171 100 | 0,31% | Option d'achat |
| MILLENNIUM MANAGEMENT LLC | $102 958 925 | 165 120 | 0,30% | Actions |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $102 237 489 | 163 963 | 0,29% | Actions |
| Bronte Capital Management Pty Ltd. | $101 398 828 | 162 618 | 0,29% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $100 247 789 | 160 258 | 0,29% | Actions |
| RAYMOND JAMES FINANCIAL INC | $99 201 835 | 159 095 | 0,29% | Actions |
| RHUMBLINE ADVISERS | $98 390 781 | 157 794 | 0,28% | Actions |
| Pictet Asset Management Holding SA | $96 459 212 | 153 500 | 0,28% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $92 422 346 | 148 222 | 0,27% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $92 259 602 | 147 961 | 0,27% | Actions |
| AMERIPRISE FINANCIAL INC | $90 305 429 | 144 827 | 0,26% | Actions |
| MACKENZIE FINANCIAL CORP | $84 666 132 | 135 783 | 0,24% | Actions |
| PRUDENTIAL FINANCIAL INC | $81 380 076 | 130 513 | 0,23% | Actions |
| Retirement Systems of Alabama | $79 731 436 | 127 869 | 0,23% | Actions |
| MARSHALL WACE, LLP | $79 189 580 | 127 000 | 0,23% | Option de vente |
| Sound Shore Management Inc /CT/ | $79 185 839 | 126 994 | 0,23% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $78 779 916 | 126 343 | 0,23% | Actions |
| ProShare Advisors LLC | $74 350 910 | 119 240 | 0,21% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $69 443 026 | 111 369 | 0,20% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $68 488 193 | 109 838 | 0,20% | Actions |
| Gotham Asset Management, LLC | $65 574 584 | 105 165 | 0,19% | Actions |
| Harvest Portfolios Group Inc. | $65 232 261 | 104 616 | 0,19% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $62 737 149 | 100 286 | 0,18% | Actions |
| Mariner, LLC | $61 632 002 | 98 826 | 0,18% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $61 471 693 | 98 585 | 0,18% | Actions |
| PARNASSUS INVESTMENTS, LLC | $59 471 998 | 95 378 | 0,17% | Actions |
| Davern Capital Partners, LP | $57 764 746 | 92 640 | 0,17% | Actions |
| AVIVA PLC | $57 045 180 | 91 486 | 0,16% | Actions |
| PFA Pension, Forsikringsaktieselskab | $56 561 245 | 90 710 | 0,16% | Actions |
| ARMISTICE CAPITAL, LLC | $55 999 504 | 89 809 | 0,16% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $54 996 852 | 88 201 | 0,16% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $52 429 737 | 84 084 | 0,15% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52 158 497 | 83 649 | 0,15% | Actions |
| ROYAL BANK OF CANADA | $51 450 000 | 82 513 | 0,15% | Actions |
| CWM, LLC | $51 303 491 | 66 400 | 0,15% | Actions |
| PINNACLE ASSOCIATES LTD | $50 660 926 | 81 247 | 0,15% | Actions |
| GROUPAMA ASSET MANAGMENT | $49 128 285 | 77 940 | 0,14% | Actions |
| NEOS Investment Management LLC | $48 213 359 | 77 322 | 0,14% | Actions |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $46 765 500 | 75 000 | 0,13% | Actions |
| Korea Investment CORP | $46 737 441 | 74 955 | 0,13% | Actions |
| Grantham, Mayo, Van Otterloo & Co. LLC | $46 266 668 | 74 200 | 0,13% | Actions |
| WOLVERINE TRADING, LLC | $45 925 425 | 81 900 | 0,13% | Option d'achat |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $45 875 500 | 59 375 | 0,13% | Actions |
| Woodline Partners LP | $45 265 886 | 72 595 | 0,13% | Actions |
Initiés de la société 39 initiés · 4 dirigeants · 7 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Leonard S Schleifer | Bd. Co-Chair, President & CEO | 31 décembre 2025 M | 214 523 | 0 | 0 | $0 |
| Christopher R. Fenimore | EVP Finance CFO | 18 août 2026 M | 19 984 | 0 | 0 | $0 |
| Joseph J Larosa | EVP General Counsel and Secret | 19 août 2026 M | 36 373 | 0 | 0 | $0 |
| Van Plew Daniel P | EVP & General Mgr, Industrial | 9 décembre 2025 F | 21 673 | 0 | 0 | $0 |
| Arthur F Ryan | Administrateur | 2 juillet 2026 S | 17 303 | 0 | 48 | $-434 683 |
| Craig B. Thompson | Administrateur | 2 janvier 2026 A | 775 | 0 | 0 | $0 |
| Anthony N Coles | Administrateur | 2 janvier 2026 A | 1 714 | 0 | 0 | $0 |
| Christine A Poon | Administrateur | 2 janvier 2026 A | 5 219 | 0 | 6 | $-4 252 745 |
| Michael S Brown | Administrateur | 2 janvier 2026 A | 1 703 | 0 | 0 | $0 |
| David P Schenkein | Administrateur | 8 septembre 2023 A | 240 | 0 | 0 | $0 |
| REGENERON PHARMACEUTICALS, INC. | Détenteur de 10% | 17 février 2021 C | 2 097 314 | 0 | 0 | $0 |
| Sanofi | Détenteur de 10% | 9 juin 2020 S | 279 766 | 0 | 0 | $0 |
| Pharma Ag Novartis | Détenteur de 10% | 8 novembre 2005 S | — | 0 | 0 | $0 |
| Kathryn Guarini | — | 10 août 2026 M | 603 | 0 | 1 | $-320 000 |
| Huda Y Zoghbi | — | 10 août 2026 M | 1 703 | 0 | 1 | $-640 000 |
| Joseph L Goldstein | — | 2 janvier 2026 A | 6 703 | 0 | 0 | $0 |
| George L Sing | — | 2 janvier 2026 A | 31 007 | 0 | 0 | $0 |
| George Yancopoulos | — | 31 décembre 2025 M | 310 460 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | — | 9 décembre 2021 M | 2 078 | 0 | 0 | $0 |
| Marion Mccourt | — | 7 juin 2021 M | 17 038 | 0 | 0 | $0 |
| Andrew J Murphy | — | 9 décembre 2020 A | 57 350 | 0 | 0 | $0 |
| Robert E Landry | — | 9 décembre 2020 A | 25 903 | 0 | 0 | $0 |
| Neil Stahl | — | 9 décembre 2020 A | 24 715 | 0 | 0 | $0 |
| Bonnie L Bassler | — | 19 juin 2020 M | 643 | 0 | 0 | $0 |
| VAGELOS P ROY | — | 16 décembre 2019 I | 2 200 | 0 | 0 | $0 |
| Charles A Baker | — | 2 janvier 2018 A | 9 000 | 0 | 0 | $0 |
| Robert J Terifay | — | 12 décembre 2017 A | 23 293 | 0 | 0 | $0 |
| Michael S Aberman | — | 16 décembre 2016 A | 16 498 | 0 | 0 | $0 |
| Peter Powchik | — | 16 décembre 2016 A | 2 459 | 0 | 0 | $0 |
| Douglas S Mccorkle | — | 29 décembre 2015 M | 6 866 | 0 | 0 | $0 |
| Alfred G Gilman | — | 6 août 2015 M | 8 912 | 0 | 0 | $0 |
| Robert Alexander Ingram | — | 22 mai 2015 M | 1 500 | 0 | 0 | $0 |
| Murray A Goldberg | — | 16 décembre 2014 A | 64 436 | 0 | 0 | $0 |
| Eric M Shooter | — | 12 février 2014 M | 0 | 0 | 0 | $0 |
| William Roberts | — | 18 septembre 2013 M | 13 447 | 0 | 0 | $0 |
| Stuart Kolinski | — | 3 juin 2010 M | 16 329 | 0 | 0 | $0 |
| Peter Dworkin | — | 18 décembre 2009 A | — | 0 | 0 | $0 |
| Randall Rupp | — | 13 avril 2007 M | 3 983 | 0 | 0 | $0 |
| Hans Peter Guler | — | 8 octobre 2004 M | 10 530 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC., SYMPHONY ACQUISITION SUB, INC. ×2 dépôts | 27 septembre 2023 | — | Dépôt initial | — | SEC |
| Sanofi ×17 dépôts | 17 juin 2020 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 246 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| TBXU · Direxion Shares ETF Trust | 8,55% | 357 NS | 30 avril 2026 | N-PORT |
| IBB · iShares Trust | 5,88% | 754 481 SH | 21 août 2026 | Quotidien |
| PBE · Invesco Exchange-Traded Fund Trust | 5,50% | 26 441 SH | 21 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 5,49% | 6 065 SH | 21 août 2026 | Quotidien |
| IDNA · iShares Trust | 3,88% | 11 531 SH | 21 août 2026 | Quotidien |
| PJP · Invesco Exchange-Traded Fund Trust | 3,21% | 20 530 SH | 21 août 2026 | Quotidien |
| BIB · ProShares Trust | 3,21% | 3 840 NS | 31 mai 2026 | N-PORT |
| QQQA · ProShares Trust | 2,93% | 2 168 NS | 31 mai 2026 | N-PORT |
| FTXH · First Trust Exchange-Traded Fund VI | 2,72% | 1 579 NS | 30 juin 2026 | N-PORT |
| AGNG · Global X Funds | 2,48% | 3 299 NS | 31 mai 2026 | N-PORT |
| SDG · iShares Trust | 2,36% | 5 119 SH | 21 août 2026 | Quotidien |
| FBT · First Trust Exchange-Traded Fund | 2,25% | 101 350 NS | 30 juin 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,19% | 344 NS | 30 avril 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2,18% | 348 NS | 30 avril 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,99% | 19 730 SH | 21 août 2026 | Quotidien |
| QQEW · First Trust Exchange-Traded Fund | 1,99% | 57 866 NS | 30 juin 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,98% | 24 491 NS | 30 avril 2026 | N-PORT |
| QQXT · First Trust Exchange-Traded Fund | 1,89% | 5 032 NS | 30 juin 2026 | N-PORT |
| SGLC · RBB Fund, Inc. | 1,87% | 5 922 NS | 31 mai 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,78% | 1 346 NS | 30 avril 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,70% | 38 010 SH | 21 août 2026 | Quotidien |
| TECB · iShares Trust | 1,68% | 9 957 SH | 21 août 2026 | Quotidien |
| HRTS · Tema ETF Trust | 1,67% | 1 408 NS | 31 mai 2026 | N-PORT |
| QNXT · iShares Trust | 1,54% | 539 SH | 21 août 2026 | Quotidien |
| BBP · ETFis Series Trust I | 1,52% | 1 276 NS | 30 avril 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,44% | 854 NS | 30 avril 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,40% | 43 095 NS | 30 avril 2026 | N-PORT |
| IYH · iShares Trust | 1,29% | 60 293 SH | 21 août 2026 | Quotidien |
| FLAG · Global X Funds | 1,29% | 30 NS | 30 avril 2026 | N-PORT |
| NUGO · Nushares ETF Trust | 1,27% | 50 872 NS | 30 avril 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,19% | 1 758 NS | 31 mai 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,19% | 4 569 NS | 30 avril 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,18% | 47 616 NS | 30 avril 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,17% | 299 615 NS | 30 avril 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,16% | 770 NS | 30 avril 2026 | N-PORT |
| IMCV · iShares Trust | 1,14% | 16 376 SH | 21 août 2026 | Quotidien |
| CURE · Direxion Shares ETF Trust | 1,03% | 2 010 NS | 30 avril 2026 | N-PORT |
| RND · First Trust Exchange-Traded Fund VI | 1,03% | 79 NS | 30 juin 2026 | N-PORT |
| IXJ · iShares Trust | 1,00% | 52 534 SH | 21 août 2026 | Quotidien |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,99% | 444 NS | 30 avril 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,99% | 540 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,95% | 312 338 SH | 19 août 2026 | Quotidien |
| FLCV · Federated Hermes ETF Trust | 0,90% | 1 412 NS | 31 mai 2026 | N-PORT |
| RXL · ProShares Trust | 0,90% | 1 051 NS | 31 mai 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,87% | 14 942 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,85% | 6 267 NS | 30 avril 2026 | N-PORT |
| RDVY · First Trust Exchange-Traded Fund VI | 0,85% | 334 208 NS | 30 juin 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,79% | 87 NS | 31 mai 2026 | N-PORT |
| TAX · EA Series Trust | 0,78% | 324 NS | 29 mai 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,77% | 419 NS | 30 avril 2026 | N-PORT |